Clients in the Media

October 1, 2025 | GATC Health
From the White House to AI drug discovery: Dr Rahul Gupta on tackling America’s opioid crisis
Pharmaphorum
October 1, 2025 | RadioMedix
Radiopharma pipeline builds ahead of key data
Nature Cancer
September 29, 2025 | Biolinq
Biolinq’s color-coded glucose sensor patch nets FDA clearance 
Fierce Biotech  
September 24, 2025 | Life Biosciences
Boston’s Breakthroughs In Biotech
The Boston Globe
September 24, 2025 | Sparrow Pharmaceutials
Finance Watch: Sparrow Flies Into Late-Stage Development With $95m Financing
Scrip + Citeline
September 24, 2025 | Sparrow Pharmaceutials
Sparrow flies forward with the $95M series B for midstage diabetes asset
Fierce Biotech
September 24, 2025 | Sparrow Pharmaceutials
RA and Forbion back Sparrow’s $95M Series B for type 2 diabetes drug
Endpoints
September 8, 2025 | GATC Health
5 Companies Caught on a Carousel of FDA Confusion
BioSpace
September 3, 2025 | RadioMedix
Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand
Labiotech
September 2, 2025 | GATC Health
New Wave of ALS Therapies Signals Renaissance After Incremental Regression
BioSpace